RLI (RLI) investor relations material

Executive summary

• Net premiums earned rose 3% year-over-year, led by the casualty segment, while net investment income increased 15% due to a larger asset base and higher reinvestment rates.

• Underwriting income reached $58 million with a combined ratio of 86.0, supported by favorable prior-year reserve development and offset by catastrophe losses and increased expenses.

• Operating earnings were $0.83 per share (down from $0.89), and GAAP net earnings were $0.60 per share (down from $0.68), impacted by $39 million in unrealized equity losses.

• Book value per share increased 2% from year-end 2025, reaching $19.54, including dividends.

• The business remains disciplined amid increased competition, focusing on rate adequacy, risk selection, and leveraging data and AI for operational efficiency.

Financial highlights

• Net premiums earned grew 3.3% year-over-year to $411.4 million, with consolidated revenue up 4% to $423.9 million.

• Net investment income rose 15% to $42.3 million, and net realized gains were $9.6 million, while net unrealized losses on equity securities totaled $39.4 million.

• Operating cash flow was $43 million, down $60 million from last year due to tax credit purchases, bonuses, and higher paid losses.

• Comprehensive earnings dropped 68.3% to $29.5 million due to after-tax unrealized losses from the fixed income portfolio.

• Book value per share increased 2% from year-end 2025 after adjusting for dividends.

Outlook and guidance

• Growth is expected to persist in casualty and transportation, with strong new business pipelines and continued rate increases.

• Management remains focused on disciplined underwriting, rate adequacy, and strategic capital deployment in a dynamic market.

• Continued investment in technology and talent to support organic growth and efficiency.

• Liquidity and capital resources are considered sufficient for the next 12–24 months, with additional capacity available if needed.

• Forward-looking statements caution about risk factors that could materially affect future results.